MedPath
HSA Approval

APO-QUETIAPINE TABLET 100MG

SIN14343P

APO-QUETIAPINE TABLET 100MG

APO-QUETIAPINE TABLET 100MG

April 25, 2013

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N05AH04

quetiapine

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC.

Active Ingredients

QUETIAPINE FUMARATE 115.06MG EQV QUETIAPINE

100MG

Quetiapine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-QUETIAPINE TABLET 100MG - HSA Approval | MedPath